Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Frozen section assessment in testicular and paratesticular lesions suspicious for malignancy: its role in preventing unnecessary orchiectomy.

Subik MK, Gordetsky J, Yao JL, di Sant'Agnese PA, Miyamoto H.

Hum Pathol. 2012 Sep;43(9):1514-9. doi: 10.1016/j.humpath.2011.11.013. Epub 2012 Mar 8.

PMID:
22406369
2.

The role of periprostatic and periseminal vesicle lymph node metastasis in the staging and prognosis of prostate cancer.

Subik MK, Yao JL, di Sant'Agnese PA, Miyamoto H.

Histopathology. 2012 May;60(6):1009-10. doi: 10.1111/j.1365-2559.2011.04101.x. Epub 2012 Feb 28. No abstract available.

PMID:
22372986
3.

Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

Arbini AA, Greco M, Yao JL, Bourne P, Marra E, Hsieh JT, di Sant'agnese PA, Moro L.

Am J Pathol. 2011 May;178(5):2367-76. doi: 10.1016/j.ajpath.2011.01.050.

4.

Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2.

Moro L, Arbini AA, Yao JL, di Sant'Agnese PA, Marra E, Greco M.

Cell Death Differ. 2009 Apr;16(4):571-83. doi: 10.1038/cdd.2008.178. Epub 2008 Dec 12.

5.

Tissue elasticity properties as biomarkers for prostate cancer.

Hoyt K, Castaneda B, Zhang M, Nigwekar P, di Sant'agnese PA, Joseph JV, Strang J, Rubens DJ, Parker KJ.

Cancer Biomark. 2008;4(4-5):213-25. Review.

6.

CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers.

Simon RA, di Sant'Agnese PA, Huang LS, Xu H, Yao JL, Yang Q, Liang S, Liu J, Yu R, Cheng L, Oh WK, Palapattu GS, Wei J, Huang J.

Hum Pathol. 2009 Feb;40(2):252-8. doi: 10.1016/j.humpath.2008.07.014. Epub 2008 Oct 5.

PMID:
18835619
7.

Expression of claudin-7 in benign kidney and kidney tumors.

Li L, Yao JL, di Sant'Agnese PA, Bourne PA, Picken MM, Young AN, Shen SS, Huang J.

Int J Clin Exp Pathol. 2008 Jan 1;1(1):57-64.

8.

Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid differentiation.

Simon RA, di Sant'agnese PA, Palapattu GS, Singer EA, Candelario GD, Huang J, Yao JL.

Int J Clin Exp Pathol. 2008 Jan 1;1(2):180-4.

9.

Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors.

Li L, Xu H, Spaulding BO, Cheng L, Simon R, Yao JL, di Sant'Agnese PA, Bourne PA, Huang J.

Hum Pathol. 2008 Aug;39(8):1205-11. doi: 10.1016/j.humpath.2007.12.012. Epub 2008 Jun 10.

PMID:
18547613
10.

Soft tissue tumors of the prostate: a review.

Wagner DG, Yao JL, di Sant'Agnese PA, Cheng L, Lopez-Beltran A, Montironi R, Huang J.

Anal Quant Cytol Histol. 2007 Dec;29(6):341-50. Review.

PMID:
18225389
11.

Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9.

Moro L, Arbini AA, Yao JL, di Sant'Agnese PA, Marra E, Greco M.

Cancer Sci. 2008 Mar;99(3):553-63. doi: 10.1111/j.1349-7006.2007.00719.x. Epub 2007 Dec 27. Erratum in: Cancer Sci. 2014 Jul;105(7):932.

12.

Function and molecular mechanisms of neuroendocrine cells in prostate cancer.

Huang J, Wu C, di Sant'Agnese PA, Yao JL, Cheng L, Na Y.

Anal Quant Cytol Histol. 2007 Jun;29(3):128-38. Review.

PMID:
17672372
13.

Extrapulmonary small cell carcinomas express K homology domain containing protein overexpressed in cancer, but carcinoid tumors do not.

Simon R, Bourne PA, Yang Q, Spaulding BO, di Sant'Agnese PA, Wang HL, Xu H.

Hum Pathol. 2007 Aug;38(8):1178-83. Epub 2007 May 22.

PMID:
17521698
14.

[Neuroendocrine differentiation in prostate cancer].

Wu CY, Na YQ, Yao JL, di Sant'Agnese PA, Huang JT.

Zhonghua Bing Li Xue Za Zhi. 2006 Sep;35(9):565-7. Chinese. No abstract available.

PMID:
17134555
15.

Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54.

Yang Z, Chang YJ, Miyamoto H, Yeh S, Yao JL, di Sant'Agnese PA, Tsai MY, Chang C.

Endocrinology. 2007 Mar;148(3):1340-9. Epub 2006 Nov 16.

PMID:
17110431
16.

Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth.

Yang Z, Chang YJ, Miyamoto H, Ni J, Niu Y, Chen Z, Chen YL, Yao JL, di Sant'Agnese PA, Chang C.

Mol Endocrinol. 2007 Feb;21(2):343-58. Epub 2006 Nov 2.

PMID:
17082327
17.

Androgen receptor in sertoli cell is essential for germ cell nursery and junctional complex formation in mouse testes.

Wang RS, Yeh S, Chen LM, Lin HY, Zhang C, Ni J, Wu CC, di Sant'Agnese PA, deMesy-Bentley KL, Tzeng CR, Chang C.

Endocrinology. 2006 Dec;147(12):5624-33. Epub 2006 Sep 14.

PMID:
16973730
18.

Immunohistochemical characterization of neuroendocrine cells in prostate cancer.

Huang J, Yao JL, di Sant'Agnese PA, Yang Q, Bourne PA, Na Y.

Prostate. 2006 Sep 15;66(13):1399-406.

PMID:
16865726
19.

Protein tyrosine phosphatase PTP1B is involved in neuroendocrine differentiation of prostate cancer.

Wu C, Zhang L, Bourne PA, Reeder JE, di Sant'Agnese PA, Yao JL, Na Y, Huang J.

Prostate. 2006 Aug 1;66(11):1125-35.

PMID:
16652382
20.

Prostate cancer: three-dimensional sonoelastography for in vitro detection.

Taylor LS, Rubens DJ, Porter BC, Wu Z, Baggs RB, di Sant'Agnese PA, Nadasdy G, Pasternack D, Messing EM, Nigwekar P, Parker KJ.

Radiology. 2005 Dec;237(3):981-5. Epub 2005 Oct 26.

PMID:
16251396
21.

Overexpression of decoy receptor 3 in precancerous lesions and adenocarcinoma of the esophagus.

Li H, Zhang L, Lou H, Ding I, Kim S, Wang L, Huang J, Di Sant'Agnese PA, Lei JY.

Am J Clin Pathol. 2005 Aug;124(2):282-7.

PMID:
16040301
22.

Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer.

Huang J, Yao JL, Zhang L, Bourne PA, Quinn AM, di Sant'Agnese PA, Reeder JE.

Am J Pathol. 2005 Jun;166(6):1807-15.

23.

Cell culture block array for immunocytochemical study of protein expression in cultured cells.

Li R, Ni J, Bourne PA, Yeh S, Yao J, di Sant'Agnese PA, Huang J.

Appl Immunohistochem Mol Morphol. 2005 Mar;13(1):85-90.

PMID:
15722799
24.

Frequent expression of human carcinoma-associated antigen, a mucin-type glycoprotein, in cells of prostatic carcinoma.

Li R, Yao JL, Bourne PA, di Sant'Agnese PA, Huang J.

Arch Pathol Lab Med. 2004 Dec;128(12):1412-7.

PMID:
15578886
25.

Phyllodes tumor of the prostate: long-term followup study of 23 cases.

Bostwick DG, Hossain D, Qian J, Neumann RM, Yang P, Young RH, di Sant'agnese PA, Jones EC.

J Urol. 2004 Sep;172(3):894-9.

PMID:
15310992
26.

Overexpression of human carcinoma-associated antigen in urothelial carcinoma of the bladder.

Yao JL, Bourne PA, Yang Q, Lei J, di Sant'Agnese PA, Huang J.

Arch Pathol Lab Med. 2004 Jul;128(7):785-7.

PMID:
15214822
27.

Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells.

Xie S, Lin HK, Ni J, Yang L, Wang L, di Sant'Agnese PA, Chang C.

Prostate. 2004 Jun 15;60(1):61-7.

PMID:
15129430
28.

Three-dimensional registration of prostate images from histology and ultrasound.

Taylor LS, Porter BC, Nadasdy G, di Sant'Agnese PA, Pasternack D, Wu Z, Baggs RB, Rubens DJ, Parker KJ.

Ultrasound Med Biol. 2004 Feb;30(2):161-8.

PMID:
14998668
29.

Renal oncocytosis presenting in childhood: a case report.

Chen TS, McNally M, Hulbert W, Di Sant'Agnese PA, Huang J.

Int J Surg Pathol. 2003 Oct;11(4):325-9.

PMID:
14615833
30.

Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein.

Na X, Duan HO, Messing EM, Schoen SR, Ryan CK, di Sant'Agnese PA, Golemis EA, Wu G.

EMBO J. 2003 Aug 15;22(16):4249-59.

31.

Grade progression and regression in recurrent urothelial cancer.

Borhan A, Reeder JE, O'Connell MJ, Wright KO, Wheeless LL, di Sant'Agnese PA, McNally ML, Messing EM.

J Urol. 2003 Jun;169(6):2106-9.

PMID:
12771728
32.

Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.

Fisher TL, Nocera M, Willis RA, Turner MJ, Abdul Alim CS, Brown DM, Bourne PA, di Sant'Agnese PA, Messing EM, Lord EM, Frelinger JG.

Prostate. 2002 May 15;51(3):153-65.

PMID:
11967950
33.

Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.

di Sant'Agnese PA.

Ann Oncol. 2001;12 Suppl 2:S135-40. Review.

PMID:
11762341
34.

Calcitonin and calcitonin gene-related peptide in the human prostate gland.

Abrahamsson PA, Dizeyi N, Alm P, di Sant'Agnese PA, Deftos LJ, Aumüller G.

Prostate. 2000 Aug 1;44(3):181-6.

PMID:
10906733
35.

Neuroendocrine differentiation in prostatic carcinoma: an update.

di Sant'Agnese PA.

Prostate Suppl. 1998;8:74-9. Review.

PMID:
9690666
36.

Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma.

Abrahamsson PA, Cockett AT, di Sant'Agnese PA.

Prostate Suppl. 1998;8:37-42.

PMID:
9690662
37.
38.

Characterization of the cell-specific expression of parathyroid hormone-related protein in normal and neoplastic prostate tissue.

Wu G, Iwamura M, di Sant'Agnese PA, Deftos LJ, Cockett AT, Gershagen S.

Urology. 1998 May;51(5A Suppl):110-20.

PMID:
9610565
39.

Energy charge monitoring via magnetic resonance spectroscopy 31P in the perfused human placenta: effects of cadmium, dinitrophenol and iodoacetate.

Malek A, Miller RK, Mattison DR, Kennedy S, Panigel M, di Sant'Agnese PA, Jessee L.

Placenta. 1996 Sep;17(7):495-506.

PMID:
8899879
40.

Exploration of new pathologic factors in terms of potential for prognostic significance and future applications.

von Eschenbach AC, Brawer MK, di Sant'Agnese PA, Humphrey PA, Mahran H, Murphy GP, Sebo TJ, Veltri R.

Cancer. 1996 Jul 15;78(2):372-5. No abstract available.

PMID:
8674021
41.

Neuroendocrine differentiation in prostatic malignancy.

di Sant'Agnese PA, Cockett AT.

Cancer. 1996 Jul 15;78(2):357-61. Review.

PMID:
8674017
42.

Immunoassay and immunohistology studies of chromogranin A as a neuroendocrine marker in patients with carcinoma of the prostate.

Deftos LJ, Nakada S, Burton DW, di Sant'Agnese PA, Cockett AT, Abrahamsson PA.

Urology. 1996 Jul;48(1):58-62.

PMID:
8693652
43.

Calcitonin receptor mRNA expression in the human prostate.

Wu G, Burzon DT, di Sant'Agnese PA, Schoen S, Deftos LJ, Gershagen S, Cockett AT.

Urology. 1996 Mar;47(3):376-81.

PMID:
8633405
44.

Immunohistochemical localization of parathyroid hormone-related protein in prostatic intraepithelial neoplasia.

Iwamura M, Gershagen S, Lapets O, Moynes R, Abrahamsson PA, Cockett AT, Deftos LJ, di Sant'Agnese PA.

Hum Pathol. 1995 Jul;26(7):797-801.

PMID:
7628854
45.

Continuous measurement of ATP by 31P-NMR in term human dually perfused placenta in vitro: response to ischemia.

Malek A, Miller RK, Mattison DR, Ceckler T, Panigel M, di Sant'Agnese PA, Jessee LN.

J Appl Physiol (1985). 1995 May;78(5):1778-86.

PMID:
7649912
48.

Androgen receptor immunostaining and its tissue distribution in formalin-fixed, paraffin-embedded sections after microwave treatment.

Iwamura M, Abrahamsson PA, Benning CM, Cockett AT, di Sant'Agnese PA.

J Histochem Cytochem. 1994 Jun;42(6):783-8.

PMID:
8189040
49.

Overexpression of human epidermal growth factor receptor and c-erbB-2 by neuroendocrine cells in normal prostatic tissue.

Iwamura M, di Sant'agnese PA, Wu G, Benning CM, Cockett AT, Gershagen S.

Urology. 1994 Jun;43(6):838-43.

PMID:
7910990
50.

Parathyroid hormone-related protein is expressed by prostatic neuroendocrine cells.

Iwamura M, Wu G, Abrahamsson PA, di Sant'Agnese PA, Cockett AT, Deftos LJ.

Urology. 1994 May;43(5):667-74.

PMID:
8165767

Supplemental Content

Loading ...
Support Center